The authors look at challenges and considerations to continuously improve inspection efficiency.
Andreas Pfenninger
Advertisement
Andreas Pfenninger is member of the management team, Registration, Production, Quality, Environmental Protection, Interpharma.
Articles by Andreas Pfenninger
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has conducted an annual survey of GMP/GDP inspections at sites and affiliates among its member companies from 2003 until the present time. This article describes findings of the EFPIA annual survey of site inspections among its member companies.
Advertisement
Latest Updated Articles
The GMP/GDP Inspection Landscape—Part I: DataPublished: January 2nd 2017 | Updated:
The GMP/GDP Inspections Landscape—Part II: Considerations and OpportunitiesPublished: February 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
